Abstract
A new factor-independent megakaryoblastic cell line, designated SET-2, was established from the peripheral blood of a patient with leukemic transformation of essential thrombocythemia (ET). SET-2 expressed CD 4, 7, 13, 33, 34, 36, 38, 41, 61, 71, 117, 126, 130 and c-mpl. In addition, it spontaneously produced numerous platelet-like particles in liquid culture. These particles were shown to be the same size as normal platelets, and to express CD 36, 38, 41, 61 and 71. Proliferation of SET-2 was not influenced by thrombopoietin (TPO) and other hemopoietic cytokines. SET-2 was found to express the platelet-specific proteins such as platelet factor 4 and β-thromboglobulin. The levels of expression were not altered by TPO. SET-2 also secreted interleukin-6 into the supernatants, as well as normal megakaryocytes. These results suggest that SET-2 spontaneously matures to megakaryocytes and produces platelet-like particles. These findings indicate that SET-2 may be useful for investigating the proliferation and differentiation mechanisms of leukemia cells and the role of c-mpl on megakaryoblasts, megakaryocytes, and platelets in ET.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fugman DA, Witte DP, Jones CLA, Aronow BJ, Lieberman MA . In vitro establishment and characterization of a human megakaryoblastic cell line Blood 1990 75: 1252–1261
Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H . Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome Blood 1985 66: 1384–1392
Sato T, Fuse A, Eguchi M, Hayashi Y, Ryo R, Adachi M, Kishimoto Y, Teramura M, Mizoguchi H, Shima Y, Komori I, Sunami S, Okimoto Y, Nakajima H . Establishment of a human leukemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia Br J Haematol 1989 72: 184–190
Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang Y-C, Pegoraro L, Clark SC . M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3 J Cell Physiol 1990 145: 458–464
Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y . Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte–macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival Cancer Res 1991 51: 341–348
Takeuchi S, Sugito S, Uemura Y, Miyagi T, Kubonishi I, Taguchi H, Enzan H, Ohtsuki Y, Miyoshi I . Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo Leukemia 1992 6: 588–594
Mouthon MA, Freund M, Titeux M, Katz A, Guichard J, Breton-Gorius J, Vainchenker W . Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis Blood 1994 84: 1085–1097
Abe A, Emi N, Kato H, Adachi K, Murate T, Saga S, Ogura M, Kojima T, Tanimoto M, Morishita N, Kawashima K, Saito H . Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2 Leukemia 1995 9: 341–349
Tsuyuoka R, Takahashi T, Suzuki A, Sasaki Y, Nakamura K, Fukumoto M, Ohmori K, Ohno Y, Nakao K . A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-likeparticles Stem Cells 1995 13: 54–64
Allen RJ, Smith SD, Moldwin RL, Lu MM, Giordano L, Vignon C, Suto Y, Harden A, Tomek R, Veldman T, Ried T, Larson RA, Le Beau MM, Rowley JD, Zeleznik-Le N . Establishment and characterization of a megakaryoblast cell line with amplification of MLL Leukemia 1998 12: 1119–1127
Matsumura I, Kanakura Y, Kato T, Ikeda H, Ishikawa J, Horikawa Y, Hashimoto K, Moriyama Y, Tsujimura T, Nishiura T, Miyazaki H, Matsuzawa Y . Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin Blood 1995 86: 703–709
Drexler HG, Quentmeier H . Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells Leukemia 1996 10: 1405–1421
Drexler HG, Zaborski M, Quentmeier H . Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines Leukemia 1996 11: 541–551
Matsumura I, Kanakura Y, Ikeda H, Ishikawa J, Yoshida H, Horikawa Y, Nishiura T, Tahara T, Kato T, Miyazaki H, Matsuzawa Y . Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells Leukemia 1996 10: 91–94
Komatsu N, Kunitama M, Yamada M, Hagiwara T, Kato T, Miyazaki H, Eguchi M, Yamamoto M, Yasusada M . Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO Blood 1996 87: 4552–4560
Takeuchi K, Ogura M, Saito H, Satoh M, Takeuchi M . Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01) Exp Cell Res 1991 193: 223–226
Murphy S, IIand H, Rosenthal D, Laszol J . Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group Semin Hematol 1986 23: 177–182
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625
Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samel B, Nichol JL, Swift S, Johonson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Choi E, Pangelinan M, Sun Y, Mar V, McNinch MJ, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sleu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Castillo JD, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA . Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl Cell 1994 77: 1117–1124
ISCN. Mitelman F (ed). An international system for human cytogenetic nomenclature. S Karger: Basel, 1995
Chang KL, Chen YY, Shibata D, Weiss LM . Description of an in-situ hybridization methodology for detection of Epstein–Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissue Diagn Mol Pathol 1992 1: 246–255
Jeffreys AJ, Turner M, Debenham P . The efficiency of multilocus DNA fingerprint probes for individualization and establishment of family relationships, determined from extensive casework Am J Hum Genet 1991 48: 824–840
Häne B, Tümmler M, Jäger K, Schleithoff L, Janssen JWG, Drexler HG . Differences in DNA fingerprints of continuous leukemia–lymphoma cell lines from different sources Leukemia 1992 6: 1129–1133
MacLeod RAF, Dirks WG, Reid YA, Hay RJ, Drexler HG . Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting Leukemia 1997 11: 2032–2038
Tahara T, Usuki K, Sato H, Ohashi H, Morita H, Tsumura H, Matsumoto A, Miyazaki H, Urabe A, Kato T . A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders Br J Haematol 1996 93: 783–788
Kato T, Ogami K, Shimada Y, Iwamatsu A, Sohma Y, Akahori H, Horie K, Kokubo A, Kudo Y, Maeda E, Kobayashi K, Ohashi H, Ozawa T, Inoue H, Kawamura K, Miyazaki H . Purification and characterization of thrombopoietin J Biochem 1995 118: 229–236
Knowles BB, Howe CC, Aden DP . Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen Science 1980 209: 497–499
Mosmann T . Rapid colorimetric assay for cellular growth andsurvival. Application to proliferation and cytotoxicity assays J Immunol Meth 1983 65: 55–63
Kobayashi E, Nakano H, Morimoto M, Tamaoki T . Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C Biochem Biophys Res Commun 1989 159: 548–553
Sanger F, Nicklen S, Coulson AR . DNA sequencing with chain terminating inhibitors Proc Natl Acad Sci USA 1977 74: 5463–5467
Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P . Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional Blood 1995 85: 402–413
Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 460–462
Yoshida H, Kondo M, Ichihashi T, Hashimoto N, Inazawa J, Ohno R, Naoe T . A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification Cancer Genet Cytogenet 1998 100: 21–24
Hassan HT, Freund M . Review of megakaryoblastic cell lines. Characteristic biological features of human megakaryoblastic leukemia cell lines Leukemia Res 1995 19: 589–594
Komatsu N, Suda T, Moroi M, Tokuyama N, Sakata Y, Okada M, Nishida T, Hirai Y, Sato T, Fuse A, Miura Y . Growth and differentiation of a human megakaryoblastic cell line, CMK Blood 1989 74: 42–48
Nagano T, Ohga S, Kishimoto Y, Kimura T, Yasunaga K, Adachi M, Ryo R, Sato T . Ultrastructural analysis of platelet-like particles from a human megakaryocytic leukemia cell line (CMK 11–5) Int J Hematol 1992 56: 67–78
Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG . Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells Leukemia 1996 10: 297–310
Takeuchi K, Satoh M, Kuno H, Yoshida T, Kondo H, Takeuchi M . Platelet-like particle formation in the human megakaryoblastic leukaemia cell lines, MEG-01 and MEG-01s Br J Haematol 1998 100: 436–444
Rao AK, Carvalho ACA . Acquired qualitative platelet defects. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds). Hemostasis and Thrombosis: Basic Principles and Clinical Practice 3rd edn JB Lippincott Co: Philadelphia 1994 685–704
Iwai K, Miyawaki T, Takazaki T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N . Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils Blood 1994 84: 1201–1208
Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y . Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells Blood 1995 86: 883–889
Hu ZB, Ma W, Uphoff CC, Quentmeier H, Drexler HG . c-kit expression in human megakaryoblastic leukemia cell lines Blood 1994 83: 2133–2144
Morita S, Tsuchiya S, Fujie H, Itano M, Ohashi Y, Minegishi M, Imaizumi M, Endo M, Takano N, Konno T . Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture Leukemia 1996 10: 102–105
Adachi M, Ryo R, Sato T, Yamaguchi N . Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK 11–5) Exp Hematol 1991 19: 923–927
Sasaki Y, Takahashi T, Tanaka I, Nakamura K, Okuno Y, Nakagawa O, Narumiya S, Nakao K . Expression of prostacyclin receptor in human megakaryocytes Blood 1997 90: 1039–1046
Alexander WS, Metcalf D, Dunn AR . Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity EMBO J 1995 22: 5569–5578
Onishi M, Mui AL-F, Morikawa Y, Cho L, Kinoshita S, Nolan GP, Gorman DM, Miyajima A, Kitamura T . Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer Blood 1996 88: 1399–1406
Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y . Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia Blood 1997 90: 4031–4038
Kiladjian JJ, Elkassar N, Hetet G, Briere J, Grandchamp B, Gardin C . Study of the thrombopoietin receptor in essential thrombocythemia Leukemia 1997 11: 1821–1826
Guerriero R, Testa U, Gabbianelli M, Mattia G, Montesoro E, Macioce G, Pace A, Ziegler B, Hassan HJ, Peschle C . Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture Blood 1995 86: 3725–3736
Navarro S, Debili N, Le Couedic JP, Klein B, Breton-Gorius J, Doly J, Vainchenker W . Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication Blood 1991 77: 461–471
Wickenhauser C, Lorenzen J, Thiele J, Hillienhof A, Jungheim K, Schmitz B, Hansmann ML, Fisher R . Secretion of cytokines (interleukin-1α, −3, and −6 and granulocyte–macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes Blood 1995 85: 685–691
Fuse A, Kakuda H, Shima Y, Van Damme J, Billiau A, Sato T . Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK Br J Haematol 1991 77: 32–36
Acknowledgements
We thank Dr K Ueno (Division of Persistent and Oncogenic Viruses, Center for Chronic Viral Diseases, Faculty of Medicine, Kagoshima University, Kagoshima, Japan) for his technical help in the detection of EB virus infection using EBER-1 ISH method, and Dr T Tanaka (Teijin Bio Laboratories, Tokyo, Japan) for the help provided in performing the DNA fingerprinting.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uozumi, K., Otsuka, M., Ohno, N. et al. Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles. Leukemia 14, 142–152 (2000). https://doi.org/10.1038/sj.leu.2401608
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401608
Keywords
This article is cited by
-
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis
Nature Communications (2023)
-
Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model
Investigational New Drugs (2022)
-
SOX6 blocks the proliferation of BCR-ABL1+ and JAK2V617F+ leukemic cells
Scientific Reports (2019)
-
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
Scientific Reports (2019)
-
Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
Cell Death & Disease (2018)